PALO ALTO, Calif., Oct. 24, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it was selected by The Ohio State University to equip a new multi-room proton therapy center in central Ohio with the ProBeam 360° system. This new proton facility is a collaboration between The Ohio Sta

ZUG, Switzerland, Oct. 24, 2019 /PRNewswire/ -- Swiss pharmaceutical company Primex Pharmaceuticals AG announces the appointment of Mr. Dan Spacie, as Global Commercial Head to the Executive Management Team led by CEO Alan Knox.Dan Spacie has joined Primex Pharmaceu

TORONTO, Oct. 24, 2019 /PRNewswire/ - Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF)

FORT WORTH, Texas, Oct. 24, 2019 /PRNewswire/ -- Galderma, a global leader in skin health focused on developing innovative aesthetic solutions, continues its strong investment in products and research that advance the aesthetics industry with seven new clinical studies recently initiated.

NORTH READING, Mass., Oct. 24, 2019 /PRNewswire/ -- TraceLink Inc., the world's largest integrated digital supply network providing real-time information sharing for better patient ou

WASHINGTON, Oct. 24, 2019 /PRNewswire/ -- After a lengthy national search, Unity Health Care (Unity) is pleased to announce the hiring of Jessica Henderson Boyd, MD, as its new Chief Medical Officer (CMO) effective November 18, 2019. Dr. Boyd comes to Unity with a wealth of leadership experience in the delivery

SOUTH PLAINFIELD, N.J., Oct. 24, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced new results from its investigational gene therapy, PTC-AADC, in patients living with aromatic L-amino acid decarboxylase (AADC) deficiency. The data demonstrated clinically meaningful and sustained improvements in motor, cognitive and language milestones.

WALTHAM, Mass., Oct. 24, 2019 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, announced today

CRANFORD, N.J., Oct. 24, 2019 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius") ("Company") (NASDAQ: CTXR), a specialty pharmaceutical company focused on developing adjunctive cancer care and critical care drug products, announced today that the Company will present at the 5th Annual Dawson James Small Cap Growth Conference on

HARTFORD, Conn., Oct. 24, 2019 /PRNewswire/ -- Aetna, a CVS Health company (NYSE: CVS), announced its 2020 Medicare offerings, featuring expanded plan options with low or $0 monthly premiums in most areas, plus enhanced benefits that focus on members' total health.